Covered recipient · General Payments record
JAWDAT A MUSTAFA
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2024
$276.23
- Reported across 16 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $276.23 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $76.68 | 4 |
| Insulet Corporation | $41.15 | 2 |
| Exact Sciences Corporation | $34.57 | 2 |
| E.R. Squibb & Sons, L.L.C. | $34.24 | 2 |
| Lilly USA, LLC | $27.89 | 2 |
| Amgen Inc. | $18.70 | 1 |
| Acerta Pharma LLC | $14.90 | 1 |
| GlaxoSmithKline, LLC. | $14.36 | 1 |
| ABBVIE INC. | $13.74 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $276.23 | 16 |
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.74 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105087943 | CMS |
| Amgen Inc. | $18.70 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117335452 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.90 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104381899 | CMS |
| E.R. Squibb & Sons, L.L.C. | $14.19 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101428490 | CMS |
| E.R. Squibb & Sons, L.L.C. | $20.05 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101428508 | CMS |
| Exact Sciences Corporation | $19.60 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114416720 | CMS |
| Exact Sciences Corporation | $14.97 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114416716 | CMS |
| GlaxoSmithKline, LLC. | $14.36 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116422639 | CMS |
| Insulet Corporation | $20.32 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116822504 | CMS |
| Insulet Corporation | $20.83 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116822502 | CMS |
| Lilly USA, LLC | $14.14 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135031492 | CMS |
| Lilly USA, LLC | $13.75 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135054972 | CMS |
| Novo Nordisk Inc | $17.29 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097668716 | CMS |
| Novo Nordisk Inc | $13.99 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096922302 | CMS |
| Novo Nordisk Inc | $27.24 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096991568 | CMS |
| Novo Nordisk Inc | $18.16 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097567319 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.